Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice - PubMed (original) (raw)
Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice
J Rodrigo et al. Neuroscience. 2004.
Abstract
Changes in the amyloid-peptide (Abeta), neuronal and inducible nitric oxide (NO)synthase (nNOS, iNOS), nitrotyrosine, glial fibrillary acidic protein, and lectin from Lycopersicon esculentum (tomato) were investigated in the cerebral cortex of transgenic mice (Tg2576) to amyloid precursor protein (APP), by immunohistochemistry (bright light, confocal, and electron microscopy). The expression of nitrergic proteins and synthesis of nitric oxide were analyzed by immunoblotting and NOS activity assays, respectively. The cerebral cortex of these transgenic mice showed an age-dependent progressive increase in intraneuronal aggregates of Abeta-peptide and extracellular formation of senile plaques surrounded by numerous microglial and reactive astrocytes. Basically, no changes to nNOS reactivity or expression were found in the cortical mantle of either wild or transgenic mice. This reactivity in wild mice corresponded to numerous large type I and small type II neurons. The transgenic mice showed swollen, twisted, and hypertrophic preterminal and terminal processes of type I neurons, and an increase of the type II neurons. The calcium-dependent NOS enzymatic activity was higher in wild than in the transgenic mice. The iNOS reactivity, expression and calcium-independent enzymatic activity increased in transgenic mice with respect to wild mice, and were related to cortical neurons and microglial cells. The progressive elevation of NO production resulted in a specific pattern of protein nitration in reactive astrocytes. The ultrastructural study carried out in the cortical mantle showed that the neurons contained intracellular aggregates of Abeta-peptide associated with the endoplasmic reticulum, mitochondria, and Golgi apparatus. The endothelial vascular cells also contained Abeta-peptide deposits. This transgenic model might contribute to understand the role of the nitrergic system in the biological changes related to neuropathological progression of Alzheimer's disease.
Similar articles
- Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice.
Stahl T, Reimers C, Johne R, Schliebs R, Seeger J. Stahl T, et al. Eur J Neurosci. 2006 Oct;24(7):1923-34. doi: 10.1111/j.1460-9568.2006.05069.x. Eur J Neurosci. 2006. PMID: 17067295 - Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J. Carrasco J, et al. Neuroscience. 2006 Dec 28;143(4):911-22. doi: 10.1016/j.neuroscience.2006.08.054. Epub 2006 Oct 4. Neuroscience. 2006. PMID: 17027170 - The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage.
German DC, Nelson O, Liang F, Liang CL, Games D. German DC, et al. J Comp Neurol. 2005 Nov 28;492(4):469-76. doi: 10.1002/cne.20744. J Comp Neurol. 2005. PMID: 16228992 - [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C, Perruchini C, Lebouvier T, Potier MC. Duyckaerts C, et al. Bull Acad Natl Med. 2008 Feb;192(2):303-18; discussion 318-21. Bull Acad Natl Med. 2008. PMID: 18819685 Review. French. - Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.
Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC, Wegiel J. Nagele RG, et al. Neurobiol Aging. 2004 May-Jun;25(5):663-74. doi: 10.1016/j.neurobiolaging.2004.01.007. Neurobiol Aging. 2004. PMID: 15172746 Review.
Cited by
- Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.
Kristofikova Z, Ricny J, Sirova J, Ripova D, Lubitz I, Schnaider-Beeri M. Kristofikova Z, et al. Neurochem Res. 2015 Aug;40(8):1709-18. doi: 10.1007/s11064-015-1654-6. Epub 2015 Jul 19. Neurochem Res. 2015. PMID: 26189181 - Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice.
Kummer MP, Hülsmann C, Hermes M, Axt D, Heneka MT. Kummer MP, et al. J Neuroimmune Pharmacol. 2012 Mar;7(1):165-72. doi: 10.1007/s11481-011-9339-7. Epub 2012 Jan 8. J Neuroimmune Pharmacol. 2012. PMID: 22227962 - Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.
Nathan C, Calingasan N, Nezezon J, Ding A, Lucia MS, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NS, Chen J, Vodovotz Y, Kipiani K, Beal MF. Nathan C, et al. J Exp Med. 2005 Nov 7;202(9):1163-9. doi: 10.1084/jem.20051529. Epub 2005 Oct 31. J Exp Med. 2005. PMID: 16260491 Free PMC article. - Neuroprotective strategies involving ROS in Alzheimer disease.
Dumont M, Beal MF. Dumont M, et al. Free Radic Biol Med. 2011 Sep 1;51(5):1014-26. doi: 10.1016/j.freeradbiomed.2010.11.026. Epub 2010 Dec 1. Free Radic Biol Med. 2011. PMID: 21130159 Free PMC article. Review. - Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.
Zaręba-Kozioł M, Szwajda A, Dadlez M, Wysłouch-Cieszyńska A, Lalowski M. Zaręba-Kozioł M, et al. Mol Cell Proteomics. 2014 Sep;13(9):2288-305. doi: 10.1074/mcp.M113.036079. Epub 2014 Jun 3. Mol Cell Proteomics. 2014. PMID: 24895380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases